Point-of-Care Testing Featured at This Year's AACC


AACC-logo.pngPoint-of-care testing was the hot topic at this year’s American AACC-logo-(1).pngAssociation of Clinical Chemistry (AACC) Clinical Lab Expo in Atlanta, Georgia. Kalorama Information, a market research group tracking trends at the conference, noted that point-of-care (POC) testing was an area of increasing interest at the conference and the medical device industry as well. It is now an estimated $17 billion global market.

Developments featured at the show included QDx InstaLab, a fingerstick test that performs tests for diabetes, kidney disease and liver disease, and a DNA test that can diagnose chlamydia using a smartphone from Johns Hopkins University BioMEMS lab. Magellan’s own LeadCare Plus Blood Lead Testing System (cleared by the FDA in July) was part of the New Product Showcase and Kalorama’s conference summary. The conference also offered a sneak peek at the future of POC with Cepheid announcing that their Gene Expert Omni molecular point-of-care platform will be launched next year. 

Link to Kalorama’s summary here: http://www.prnewswire.com/news-releases/aacc-2015-near-patient-testing-solutions-on-display-at-convention-300124164.html
Bookmark and Share

Request More Information
* = Required

 Security code